Hillhouse Capital Advisors »

Marvell Technology shares owned by Hillhouse Capital Advisors

Quarter-by-quarter ownership of Marvell Technology (MRVL) shares owned by Hillhouse Capital Advisors from 13F filings

Historical chart of Hillhouse Capital Advisors investment in Marvell Technology

Tip: Access up to 7 years of quarterly data

All positions including Marvell Technology held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marvell Technology by Hillhouse Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $17M 171k 99.05
2024-03-31 $4.2M 60k 70.88

More positions owned by Hillhouse Capital Advisors

Pdd Holdings Sponsored Ads (PDD)
Alibaba Group Hldg Sponsored Ads (BABA)
Beone Medicines Sponsored Ads (ONC)
Futu Hldgs Spon Ads Cl A (FUTU)
Legend Biotech Corp Sponsored Ads (LEGN)
Arrivent Biopharma (AVBP)
Ke Hldgs Sponsored Ads (BEKE)
Clearwater Analytics Hldgs I Cl A (CWAN)
Cytek Biosciences (CTKB)
Marvell Technology (MRVL)
Yatsen Hldg Sponsored Ads (YSG)
Novabridge Biosciences Sponsored Ads (NBP)
Maze Therapeatics (MAZE)
Contineum Therapeutics Cl A (CTNM)
Agora Ads (API)

View all positions for Hillhouse Capital Advisors

Top funds holding Marvell Technology

FMR
Vanguard Group
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
Jane Street
State Street Corporation
Susquehanna International
Ameriprise Financial
UBS Group
Geode Capital Management
Goldman Sachs Group
Franklin Resources
Invesco
Bank of America Corporation

View all funds holding Marvell Technology